Alcon Acquired by Novartis
On December 15, 2010, Novartis (NYSE: NVS) agreed to acquire the remaining shares of Alcon, Inc. (NYSE: ACL) it doesn't currently own for $168 per share.
The merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Upon completion of the merger, Alcon will become the second largest division within Novartis. CIBA VISION and select Novartis ophthalmic medicines will be integrated into Alcon, forming an organization with more than $8.7 billion in sales covering over 70 percent of the eye care segment.
The merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Upon completion of the merger, Alcon will become the second largest division within Novartis. CIBA VISION and select Novartis ophthalmic medicines will be integrated into Alcon, forming an organization with more than $8.7 billion in sales covering over 70 percent of the eye care segment.
View Older Stories View More Recent Stories
-
Graybug Vision Inc. (GRAY) Appoints Dirk Sauer to its Board
-
Graybug Vision Appoints Dirk Sauer to Board of Directors
-
Graybug Vision Appoints Dirk Sauer to Board of Directors
-
ExteNet Systems Names Anithea Dorch as Chief Human Resources Officer
-
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
-
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
-
WEP Clinical Appoints Karl Challender as Chief Operating Officer
-
The Galien Foundation Announces Prix Galien International Awards Nominees
-
Inari Medical, Inc. (NARI) Appoints Robert Warner to its Board
-
Inari Medical Appoints Robert Warner to Board of Directors
-
Chicos FAS (CHS) Names Nike's Eli Kumekpor to Board
-
Chico's FAS, Inc. Appoints Eli Kumekpor to Board of Directors
-
EyeYon Medical Appoints Dr. Sharon Bakalash MD, PhD As Chief Medical Officer
-
Vertex Ventures HC Announces the Addition of Christine Brennan, Ph.D. as Managing Director
-
RBC Capital Sees Positive Read-Through to Bausch Health Companies (BHC) from Alcon's (ALC) EPS
-
Aleafia Health Appoints Tricia Symmes as CEO to Replace Geoffrey Benic
-
Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer
-
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
-
Opthea (OPT) Appoints Judith Robertson as CCO to Lead Commercialization of OPT-302 for Wet AMD
-
Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet AMD
-
Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet AMD
-
Alcon Continues Its Successful Rollout of PRECISION1 Daily Disposable Contact Lenses, Now Available in Key Markets Throughout Latin America, Asia & Europe
-
Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development
-
Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development
-
EQT, BioNTech investor consider bid for Novartis arm Sandoz -report
-
Medtronic taps top digital and healthcare technology leaders to drive company transformation
-
Alcon Reports Third Quarter 2021 Results
-
Alcon Reports Third Quarter 2021 Results
-
Alcon (ALC) to Acquire Ivantis for $475M Upfront
-
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
-
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
-
Novartis cuts uneasy 20-year ties to Roche with $20.7 billion voting stake sale
-
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
-
Sanford Heisler Sharp Expands Leadership Team, Promotes Five, Adds Seven Lawyers Across National Platform
-
Sanford Heisler Sharp Expands Leadership Team, Promotes Five, Adds Seven Lawyers Across National Platform
-
Huma's digital health platform wins prestigious Prix Galien USA 2021 award
-
The Galien Foundation Honors Excellence in Scientific Innovation at 2021 Prix Galien Awards Gala
-
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
-
Oculis Appoints Dr. Joanne Chang as Global Chief Medical Officer and Opens Hong Kong Office to broaden its footprint and build a strong Asia/China presence
-
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
-
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
-
Defence Therapeutics Files Acid-Based Hydrogels USA Provisional Patent Application
-
Alcon Reports Second Quarter 2021 Results
-
Alcon Reports Second Quarter 2021 Results
-
RxSight Announces Appointments to its Board of Directors
-
RxSight Announces Appointments to its Board of Directors
-
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital
-
Ault Global Holdings (DPW) to Acquire up to 40% of Adtech Pharma, Inc.
-
Ault Global Holdings Announces Agreement to Acquire up to 40% of Adtech Pharma, Inc.
-
2020 On-site Forms Industry and Scientific Advisory Board

